Scott Gottlieb, MD and the Orphan Drug Modernization Act

Sep 28, 2017 11:51:37 AM / by John Kouten, CEO posted in FDA, rare diseases, orphan drugs


Scott Gottlieb, MD, appointed as FDA commissioner in May 2017, has made some fast progress. According to the FDA Voice, The FDA has reviewed the backlog of orphan designation requests that were more than 120 days old. And they accomplished this goal on August 28, 2017 – nearly a month ahead of their September 21 deadline.

Read More